Alectinib-Induced Hemolysis in a Case of ALK-Positive Metastatic Lung Adenocarcinoma: A Case Report with Review of Literature

This is a case report of how we tumbled upon anemia due to drug-related hemolysis, a rare side effect of alectinib, which is a primary drug used in ALK-positive lung cancer. A 78-year-old male patient with history of surgery and concurrent chemoradiation for a primary adenocarcinoma lung in 2013 pre...

Full description

Saved in:
Bibliographic Details
Main Authors: Suparna Ajit Rao, Tejas Radadiya, Vidhisha Mahajan, Farah Jijina, Asha Kapadia C.
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd.
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1810058
Tags: Add Tag
No Tags, Be the first to tag this record!